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Increasing antibiotic consumption has accelerated resistance development, prompting the need for novel antibiotics ([@B1], [@B2]). Stegodyphus dumicola spiders are social spiders that live in communal nests with a high degree of inbreeding and low genetic variation, making them potentially vulnerable for pathogen attack. We therefore suggest an intricate symbiotic relationship with a well-developed protective microbiome. This microbiome may present an unexplored source of antibiotics ([@B3], [@B4]).

Bacillus subtilis SB-14 was isolated from the body surface of a *Stegodyphus dumicola* spider, as follows: a spider was immersed in nutrient broth (Sigma-Aldrich), which was incubated at 30°C overnight, plated onto nutrient broth agar plates, and grown aerobically at 30°C. Single colonies from serial dilutions were restreaked until a pure culture was established. Colonies were screened by colony PCR and 16S rRNA gene sequencing ([@B5]). The antimicrobial activity of SB-14 against Staphylococcus epidermidis BMC-HMP0060 was detected using the Kirby-Bauer disk diffusion susceptibility test protocol ([@B6]), with the modification that SB-14 was point inoculated onto a lawn of S. epidermidis.

Genomic DNA was extracted using the DNeasy blood and tissue kit (Qiagen) and prepared for sequencing with a Nextera XT DNA library prep kit (Illumina). Sequencing was performed utilizing an Illumina MiSeq platform with a paired-end 300-bp read MiSeq reagent kit, yielding ∼5.5 million sequencing reads in total (∼1.11 Gbp), with approximately 260× coverage. Read quality was analyzed by FastQC version 0.11.7 (<https://www.bioinformatics.babraham.ac.uk/projects/fastqc/>), and reads were trimmed by Trimmomatic version 0.36 ([@B7]) using length-based trimming with the following parameters: headcrop, 20; crop, 290; a minimum average quality score of 20; and a 4-bp sliding window. Finally, the genome was assembled using SPAdes version 3.11.1 ([@B8]), resulting in 37 scaffolds, of which 31 were ≥200 bp when applying the parameters --careful -k 21, 33, 55, 77, 99, 127.

CheckM version 1.0.9 ([@B9]) estimated 98.28% completeness and 0.00% contamination of the SB-14 genome, using the gene marker set for the domain *Bacteria*; the corresponding values using the gene marker set for Bacillus subtilis were 97.29% and 2.63%, respectively.

NCBI BLAST ([@B10]) analysis of the 16S rRNA gene revealed 99% identity to the 16S rRNA genes of multiple Bacillus subtilis strains. This genus and species identity was confirmed by an average amino acid identity of \>98% ([@B11]), average nucleotide identity of \>98% ([@B11]), and 94.18% digital DNA-DNA hybridization value (<http://ggdc.dsmz.de/>), compared to Bacillus subtilis subsp. inaquosorum (NCBI RefSeq accession no. [NZ_CP013984](https://www.ncbi.nlm.nih.gov/nuccore/NZ_CP013984)).

The draft genome of Bacillus subtilis SB-14 contains 4,262,181 bp on 31 scaffolds of ≥200 bp, with an average G+C content of 44.02% and an *N*~50~ value of 781,251 bp. Prokka version 1.12 ([@B12]) analysis found 81 tRNA, 10 rRNA, and 4,210 protein-coding sequences. Upon antiSMASH version 3.0 ([@B13]) analysis, 30 secondary metabolite biosynthetic gene clusters were identified. Five of these were 100% identical to known clusters encoding the biosynthesis of teichuronic acid ([@B14]), bacillibactin ([@B15]), the antifungal lipopeptide fengycin ([@B16]), and the antibiotics bacillaene ([@B17]) and subtilosin A ([@B18]). Three other clusters had 82%, 40%, and 18% identity to clusters known for the biosynthesis of the antimicrobial metabolites surfactin ([@B19]), bacillomycin ([@B20]), and zwittermicin A ([@B21]), respectively; these three may therefore represent novel variations of these metabolites.

Data availability. {#s1.1}
------------------

The isolate Bacillus subtilis SB-14 has been deposited at the DSMZ (<https://www.dsmz.de/>) under accession no. DSM 109343. This whole-genome shotgun project has been deposited in DDBJ/ENA/GenBank under BioProject accession no. [PRJNA438195](https://www.ncbi.nlm.nih.gov/bioproject/PRJNA438195). The raw data can be found under accession no. [SRR8560781](https://www.ncbi.nlm.nih.gov/Traces/study/?acc=PRJNA438195), and the assembled genome has GenBank accession no. [PXUR00000000](https://www.ncbi.nlm.nih.gov/nuccore/PXUR00000000). The version described in this paper is the first version, PXUR01000000.
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